MannKind Corporation (MNKD) stock analysis

MNKD · MannKind Corporation

Latest recorded price: USD 3.95

Sector and industry: Healthcare · Biotechnology

A reliable intrinsic value could not be calculated for MNKD; the assessment relies on sector multiple comparisons. Fiscal 2025 figures: revenue growth 51.8%, free cash flow margin 3.9%, ROIC 17.8%. The model flags 1 risk signal for this company.

Similar companies in Healthcare